Oncoinvent ASA Cash Flow Reinvestment Rate
Oncoinvent ASA cash flow reinvestment rate. Oncoinvent ASA (KLDVK) has a Cash Flow Reinvestment Rate of 0.58x as of December 2025, reinvesting Nkr2.12 Million (capex Nkr2.12 Million ) from operating cash flow of Nkr3.64 Million. See Oncoinvent ASA financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Oncoinvent ASA (2021–2022)
Cash flow reinvestment rate of Oncoinvent ASA from 2021 to 2022. Historical reinvestment intensity for Oncoinvent ASA across 2 annual periods. Explore Oncoinvent ASA (KLDVK) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Oncoinvent ASA Cash Flow Reinvestment Rate by Year (2021–2022)
Oncoinvent ASA cash flow reinvestment rate by year from 2021 to 2022. Year-by-year capital reinvestment analysis for Oncoinvent ASA. For the full cash flow conversion analysis, see Oncoinvent ASA (KLDVK) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (NOK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 32.49x | Nkr12.12 Million | Nkr373.06K | Nkr12.12 Million | ▼ -86.3% |
| 2021 | 236.36x | Nkr30.88 Million | Nkr130.66K | Nkr30.88 Million | — |